[Reduction of the left ventricular mass in essential hypertension patients chronically treated with monotherapy]

H P Baglivo1, G Fabregues, H O Burrieza

  • 1División Cardiología, Policlínica Bancaria, Buenos Aires, Argentina.

Medicina
|January 1, 1990
PubMed

Insights

Essential hypertension patients treated with atenolol, enalapril, or nifedipine showed significant blood pressure and left ventricular mass reduction. These antihypertensive drugs effectively reverse cardiac remodeling in hypertensive individuals.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Context:

  • Essential hypertension is a prevalent condition associated with increased cardiovascular risk.
  • Left ventricular mass (LVM) is a key indicator of cardiac remodeling and a predictor of cardiovascular events.
  • Current antihypertensive therapies aim to reduce blood pressure and prevent target organ damage.

Purpose:

  • To evaluate the effects of single-drug antihypertensive therapy on left ventricular mass in patients with essential hypertension.
  • To compare the efficacy of atenolol, enalapril maleate, and nifedipine in reducing LVM and blood pressure.

Summary:

  • A 12-month study involving 104 patients with mild to moderate essential hypertension compared atenolol, enalapril, and nifedipine against a no-medication control group.
  • All three drugs significantly reduced blood pressure (BP). Atenolol also reduced heart rate, while body weight remained unchanged.
  • Crucially, significant reductions in left ventricular mass (LVM) and the LVM/volume ratio were observed in patients with increased LVM across all treated groups.

Impact:

  • These findings demonstrate that common antihypertensive medications can reverse cardiac hypertrophy in hypertensive patients.
  • The study highlights the importance of LVM assessment in managing hypertension and suggests that effective BP control leads to favorable cardiac remodeling.
  • This research supports the use of atenolol, enalapril, and nifedipine for their beneficial effects on cardiac structure in hypertensive individuals.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...